| P2093 | author name string | K G Mann | |
| | M F Whelihan | |
| | M T Gissel | |
| | T Orfeo | |
| P2860 | cites work | The contribution of bovine Factor V and Factor Va to the activity of prothrombinase | Q28249212 |
| | Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis | Q28508572 |
| | Kinetics of coagulation factor X activation by platelet-bound factor IXa | Q28630360 |
| | Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity | Q28630745 |
| | Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI | Q28631030 |
| | Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII | Q28631351 |
| | A new Italian family with severe prekallikrein deficiency. Desmopressin-induced fibrinolysis and coagulation changes in homozygous and heterozygous members | Q33806053 |
| | Factor XI deficiency in Ashkenazi Jews in Israel | Q34118794 |
| | Activation of bovine factor IX (Christmas factor) by factor XIa (activated plasma thromboplastin antecedent) and a protease from Russell's viper venom | Q34255465 |
| | AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER. | Q34257237 |
| | Activation of factor VIII and mechanisms of cofactor action | Q34284793 |
| | Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency | Q34357310 |
| | The coagulation-kinin pathway of human plasma | Q34687103 |
| | A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma | Q35282990 |
| | Isolation of functional human coagulation factor V by using a hybridoma antibody | Q35302079 |
| | The influence of von Willebrand factor on factor VIII activity measurements | Q36091335 |
| | The elusive physiologic role of Factor XII | Q36841363 |
| | Intrinsic pathway of coagulation and arterial thrombosis | Q36960808 |
| | Association of factor XI and high molecular weight kininogen in human plasma | Q37049066 |
| | Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI | Q37071138 |
| | Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology | Q37373003 |
| | Thrombin-Catalyzed Activation of Recombinant Human Factor V | Q41358432 |
| | The intrinsic coagulation/kinin-forming cascade: assembly in plasma and cell surfaces in inflammation | Q41610134 |
| | pH-dependent denaturation of thrombin-activated porcine factor VIII. | Q44569115 |
| | Substrate-dependent modulation of the mechanism of factor XIa inhibition | Q45055255 |
| | Activated partial thromboplastin time (APTT). New indications for an old test? | Q45857730 |
| | The mode of inheritance of PTA deficiency: evidence for the existence of major PTA deficiency and minor PTA deficiency. | Q45866884 |
| | Blood coagulation in hemophilia A and hemophilia C. | Q45887648 |
| | Molecular weight of undegraded plasma factor V. | Q47285630 |
| | The function of factor XI in tissue factor-initiated thrombin generation | Q47592308 |
| | A method for the determination of amino acid sequence in peptides. | Q47880646 |
| | The factor V activation paradox | Q50335791 |
| | Characterization of Factor V activation intermediates. | Q50923358 |
| | A model for the stoichiometric regulation of blood coagulation. | Q52044713 |
| | Activation of porcine factor VIII:C by thrombin and factor Xa. | Q52655588 |
| | Severe coagulation factor V deficiency caused by a 4 bp deletion in the factor V gene | Q55670804 |
| | Genetic basis of total kininogen deficiency in Williams' trait | Q55670927 |
| | Thrombin-catalyzed activation of single chain bovine factor V | Q67469113 |
| | Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit | Q67987635 |
| | Thrombin | Q68236967 |
| | Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX | Q68828839 |
| | Inhibition of factor XIa by antithrombin III | Q68830528 |
| | Mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa(activated plasma thromboplastin antecedent) | Q68926747 |
| | Proteolysis of factor Va by factor Xa and activated protein C | Q69139671 |
| | The reassociation of factor Va from its isolated subunits | Q69942844 |
| | Thrombin-catalyzed activation of human coagulation factor V | Q70340079 |
| | Radioimmunoassay of factor V in human plasma and platelets | Q70366146 |
| | The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles | Q70434423 |
| | Identification of a factor IX binding site on the third apple domain of activated factor XI | Q71763368 |
| | A model for the tissue factor pathway to thrombin. I. An empirical study | Q72181568 |
| | Heredity and Coagulation Studies in Ten Families with Factor XI (Plasma Thromboplastin Antecedent) Deficiency | Q72630584 |
| | Ultrasensitive fluorogenic substrates for serine proteases | Q73866804 |
| | Thrombin functions during tissue factor-induced blood coagulation | Q74314270 |
| | Structural requirements for the activation of human factor VIII by thrombin | Q78290379 |
| | Factor XIa and tissue factor activity in patients with coronary artery disease | Q80543328 |
| | The intrinsic pathway of coagulation is essential for thrombus stability in mice | Q82506244 |
| P433 | issue | 7 | |
| P304 | page(s) | 1532-1539 | |
| P577 | publication date | 2010-05-04 | |
| P1433 | published in | Journal of Thrombosis and Haemostasis | Q6296004 |
| P1476 | title | Coagulation procofactor activation by factor XIa. | |
| P478 | volume | 8 | |